Wnt signaling in colorectal cancer: pathogenic role and therapeutic target.
Zhao H, Ming T, Tang S, Ren S, Yang H, Liu M, Tao Q, Xu H. · 2022
Read Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. by Zhao H, Ming T, Tang S, Ren S, Yang H, Liu M, Tao Q, Xu H. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9281132.txt.
Description
Zhao and co-authors review Wnt signaling as a driver and drug target in colorectal cancer. The Wnt network guides embryo growth and cell fate, and its canonical branch is a known colon cancer driver. Beta-catenin sits at the center of that branch. Its control and breakdown are key events in tumor growth.
The review lays out the three Wnt branches and their biochemistry. It links the pathway to cell growth, stemness, cell death, metabolism, and spread. Drugs, plant compounds, and molecular blockers aimed at the pathway are surveyed. Some Wnt blockers are already used in the clinic for this cancer. The authors argue that better pathway drugs could treat colorectal cancer well. Clear targets now exist at many steps of the cascade.
Catalog record
| CREATOR | Zhao H, Ming T, Tang S, Ren S, Yang H, Liu M, Tao Q, Xu H. |
|---|---|
| YEAR | 2022 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 148 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |